폐암 (NSCLC) | 바이오모아

YL201 (YL201)

Small Cell Lung Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

ADCBiologicstaleSWOG Cancer Research NetworkPhase 2

ABBV-399 (ABBV-399)

Recurrent Squamous Cell Lung Carcinoma; Stage IV Squamous Cell Lung Carcinoma AJCC V7 · Recurrent Squamous Cell Lung Carcinoma

#RecurrentSquamousCellLungCarcino#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

효능 ORR 33.3%임상시험 11상태 ACTIVE

AntibodyRochePhase 3

atezolizumab (Tecentriq, Atezolizumab and Recombinant Human Hyaluronidase)

Lung Non-Small Cell Carcinoma; Stage II Lung Cancer AJCC v8 · Lung Non-Small Cell Carcinoma

#LungNon-SmallCellCarcinoma#Antibody#Phase3#항체#면역항체+3

효능 ORR 10.5%임상시험 7상태 RECRUITING

AntibodystaleAstraZenecaPhase 3

MEDI4736 (Durvalumab, Durvalumab (MEDI4736))

Non-small Cell Lung Cancer · Non Small Cell Lung Carcinoma NSCLC

#NonSmallCellLungCarcinomaNSCLC#Antibody#Phase3#항체#면역항체+3

효능 ORR 44%임상시험 7상태 RECRUITING

ADCBiologicShanghai Junshi Bioscience Co.,…Phase 2

JS212 (JS212)

Non-squamous Non-small Cell Lung Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 7상태 RECRUITING

ADCBiologicstaleBase Therapeutics (Shanghai) Co…Phase 2

NK510 (NK510)

NSCLC · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 6상태 RECRUITING

ADCBiologicstaleAstraZenecaPhase 1

AZD7789 (AZD7789)

Advanced or Metastatic NSCLC · Advanced or Metastatic NSCLC

#AdvancedorMetastaticNSCLC#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

임상시험 5상태 RECRUITING

AntibodystaleMerck Sharp & Dohme LLCPhase 2

Boserolimab (Boserolimab)

Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#Antibody#Phase2#항체#면역항체+4

효능 ORR 7.1%임상시험 5상태 RECRUITING

ADCBiologicstaleSeagen, a wholly owned subsidia…Phase 1

sigvotatug vedotin (sigvotatug vedotin)

Carcinoma, Non-Small Cell Lung; Squamous Cell Carcinoma of Head and Neck · Carcinoma, Non-Small Cell Lung

#CarcinomaNon-SmallCellLung#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+4

임상시험 5상태 RECRUITING

ADCBiologicstaleMerck Sharp & Dohme LLCPhase 2

5-hydroxytryptamine subtype 3 receptor antagonist (5-hydroxytryptamine subtype 3 receptor antagonist)

Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

임상시험 4상태 RECRUITING

ADCBiologicstaleMultitude Therapeutics Inc.Phase 2

AMT-116 (AMT-116)

Advanced Non-small Cell Lung Cancer (NSCLC) · Advanced Non-small Cell Lung Cancer (NSC

#AdvancedNon-smallCellLungCancerN#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

임상시험 4상태 RECRUITING

ADCBiologicstaleBioNTech SEPhase 3

BNT324 (BNT324)

Advanced Lung Cancer · Metastatic Castration-resistant Prostate

#MetastaticCastration-resistantPr#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2

임상시험 4상태 RECRUITING

CGTBiologicstaleBeijing BiotechPhase 2

DLL3-CAR-NK cells (DLL3-CAR-NK cells)

Extensive Stage Lung Small Cell Cancer · SCLC, Extensive Stage

#SCLCExtensiveStage#CGT#Phase2#세포유전치료#CAR-T+3

임상시험 4상태 RECRUITING

ADCBiologicstaleBristol-Myers SquibbPhase 2

MORAb-202 (MORAb-202)

Carcinoma, Non-Small-Cell Lung · Neoplasms, Ovarian

#NeoplasmsOvarian#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

효능 ORR 20%임상시험 4상태 DISCONTINUED

AntibodystaleBeiGenePhase 1

atezolizumab (Tecentriq, Tislelizumab，atezolizumab or sugemalimab)

NSCLC · NSCLC

#NSCLC#Antibody#Phase1#항체#면역항체+2

임상시험 4상태 RECRUITING

AntibodystalePeregrine PharmaceuticalsPhase 2

bavituximab (bavituximab)

Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#Antibody#Phase2#항체#면역항체+2

효능 ORR 9%임상시험 4상태 ACTIVE

AntibodyBristol Myers SquibbPhase 2

pembrolizumab (Keytruda, ipilimumab+pembrolizumab or ipilimumab+durvalumab, idarubicin, bevacizumab)

Liver Cancer; Antibody · Lung Cancer

#LungCancer#Antibody#Phase2#항체#면역항체+3

임상시험 4상태 RECRUITING

AntibodyBristol Myers SquibbPhase 2

pembrolizumab (Keytruda, ipilimumab, pembrolizumab, durvalumab, idarubicin, bevacizumab)

Hepatic Cancer; Surgery · Lung Cancer

#LungCancer#Antibody#Phase2#항체#면역항체+4

임상시험 4상태 RECRUITING

AntibodyThe First Affiliated Hospital o…Phase 2

Adebellizumab (Adebellizumab)

Resectable Lung Non-Small Cell Carcinoma · Resectable Lung Non-Small Cell Carcinoma

#ResectableLungNon-SmallCellCarci#Antibody#Phase2#항체#면역항체+2

임상시험 3상태 RECRUITING

ADCBiologicstaleBioAtla, Inc.Phase 2

CAB-ROR2-ADC (CAB-ROR2-ADC)

Non Small Cell Lung Cancer; Triple Negative Breast Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 3상태 ACTIVE

6 / 19 페이지

← 이전 다음 →

갱신 기록 없음 · 14일 주기 · 방문 16 / 568